Below are the most recent publications written about "Defibrillators, Implantable" by people in Profiles.
-
Saylor PJ, Dudzinski DM, Mendoza DP, Glomski K. Case 14-2019: A 44-Year-Old Man with Neck Pain and Swelling. N Engl J Med. 2019 May 09; 380(19):1854-1863.
-
Afari ME, Syed W, Tsao L. Implantable devices for heart failure monitoring and therapy. Heart Fail Rev. 2018 11; 23(6):935-944.
-
Hernández-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J, Chessa M, Combes N, Dagres N, Diller G, Ernst S, Giamberti A, Hebe J, Janousek J, Kriebel T, Moltedo J, Moreno J, Peinado R, Pison L, Rosenthal E, Skinner JR, Zeppenfeld K. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 2018 11 01; 20(11):1719-1753.
-
Bitterman DS, Zei PC, Mak RH. Radiation Safety and Cardiovascular Implantable Electronic Devices. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):243-246.
-
Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? Europace. 2018 09 01; 20(9):1399-1421.
-
Zheng Q, Maytin M, John RM, Killu AM, Epstein LM. Transvenous lead extraction during uninterrupted warfarin therapy: Feasibility and outcomes. Heart Rhythm. 2018 12; 15(12):1777-1781.
-
Killu AM, Mazo A, Grupper A, Madhavan M, Webster T, Brooke KL, Hodge DO, Asirvatham SJ, Friedman PA, Glikson M, Cha YM. Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy. Europace. 2018 08 01; 20(8):1303-1311.
-
Baskar S, Veldtman GR, Khoury PR, Opotowsky AR, Cedars AM. Characteristics of hospital admissions associated with implantable cardioverter defibrillator placement among adults with congenital heart disease. Int J Cardiol. 2018 Oct 15; 269:97-103.
-
Ebrille E, Chang JD, Zimetbaum PJ. Tricuspid Valve Dysfunction Caused by Right Ventricular Leads. Card Electrophysiol Clin. 2018 09; 10(3):447-452.
-
Waks JW, Passman RS, Matos J, Reynolds M, Thosani A, Mela T, Pederson D, Glotzer TV, Zimetbaum P. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study. Heart Rhythm. 2018 11; 15(11):1601-1607.